Shaily Engineering Plastics Limited
SHAILY.NS
National Stock Exchange of India2,760.10
INR
+44.70
- -
Shaily Engineering Plastics Limited
SHAILY.NS
(National Stock Exchange of India)
Recent
price
2,760.10
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Shaily Engineering Plastics Limited engages in the design, manufacture, and sale of precision injection-molded plastic components and assemblies primarily for healthcare, pharmaceutical, consumer, personal care, automotive, and engineering sectors. Its main product portfolio includes complex precision components for drug delivery devices such as platform pen injectors, autoinjectors, inhalers, sprays, pumps, insulin injector pens, specialty packaging solutions for solid and liquid pharmaceutical formulations including primary packaging like pen devices, dry powder inhalers (DPIs), child-resistant closures (CRCs), and HDPE bottles; consumer products such as kitchen and cooking devices, storage and cleaning products; plastic and plastic/electronic toys developed in partnership with Spin Master; lighting and appliance components; automotive plastic parts; and sheet steel furniture products including cabinets and storage units. The company also provides contract development and manufacturing services to pharmaceutical companies. Its manufacturing facilities are located in Gujarat, India, including Savli and Halol, with a dedicated ISO Class 8 clean room for specialized manufacturing, and it exports products to approximately 40 countries worldwide. Founded in 1987 and headquartered in Vadodara, Gujarat, Shaily Engineering Plastics focuses on high-performance engineering polymers and commodity polymers for injection molding. In the last 1-2 years, Shaily Engineering Plastics has made significant operational and strategic developments, including a 33.7% year-over-year increase in consolidated net sales as of September 2025. The company has received the Plexconcil Best Exporter of Engineering Components of Plastics award for fiscal years 2023-24 and 2024-25. It has secured new business in the home furnishing segment from two global retail chains with supplies projected to commence in the first half of fiscal 2026. Strategic partnerships include alliances with generic pharmaceutical companies preparing to launch generic GLP-1 drugs, with exhibit batches supplied and substantial volume production expected from the second half of fiscal 2026. In 2025, prominent institutional investors like the Abu Dhabi Investment Authority acquired a significant stake in the company. Shaily continues to invest in innovation and expansion of its manufacturing capacity, holding ISO 13485 and ISO 15378 certifications ensuring compliance with quality standards in medical device and primary packaging production. Shaily Engineering Plastics operates across multiple business segments including healthcare (pharmaceutical devices and packaging), consumer goods (home furnishings, FMCG packaging), and engineering and automotive components, targeting original equipment manufacturers, pharmaceutical companies, global retail chains, and consumer markets globally. The company's approach integrates secondary operations such as vacuum metallizing, hot stamping, pad printing, and ultrasonic welding to add enhanced value to its plastic products. This comprehensive product and service offering, combined with recent expansions and strategic partnerships, positions Shaily Engineering Plastics as a leading Indian manufacturer in precision plastic components with a robust footprint in global healthcare and consumer markets. The company was established in 1987 in Vadodara, India, where its headquarters remain located. The company trades on the National Stock Exchange of India under the ticker SHAILY.NS.